Currently breast feeding.Xx_NEWLINE_xXThe subject is pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding women are excluded from this studyXx_NEWLINE_xXPregnant or breast-feeding women may not be entered on this study; pregnancy tests must be obtained in girls who are post-menarchalXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this study; pregnancy tests must be obtained in girls who are post-menarchalXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant, planning a pregnancy or breast feeding during the studyXx_NEWLINE_xXthe safety or well-being of the participant's offspring (such as through pregnancy or breast-feeding)Xx_NEWLINE_xXPatients found to be pregnant/breast feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Women must not be pregnant or breast-feedingXx_NEWLINE_xXELIGIBILITY CRITERIA - PHASE II (ARM D): Women must not be pregnant or breast-feedingXx_NEWLINE_xXPatients who are breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast-feeding women, or intending to become pregnant during the studyXx_NEWLINE_xXPregnant or breast feeding or plans to become pregnant within 6 months of AVB-620 administration.Xx_NEWLINE_xXNot breast feeding at any time during the study.Xx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXNot currently pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXWoman of childbearing potential that is pregnant or breast-feeding, or planning to become pregnant or breast-feed during protocol treatment and for 3 months after last dose of talimogene laherparepvecXx_NEWLINE_xXNot breast feeding at any time during the study.Xx_NEWLINE_xXPregnant or breast feeding females.Xx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant or are breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding females.Xx_NEWLINE_xXNot breast feeding at any time during the study.Xx_NEWLINE_xXFemales who are pregnant, breast-feeding, or planning to become pregnant within 3 months after the last dose of study drug and males who plan to father a child while enrolled in this study or within 5 months after the last dose of study drugXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXBreast feeding or pregnantXx_NEWLINE_xXPregnant, planning a pregnancy, or breast feedingXx_NEWLINE_xXWomen must not be breast-feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feeding will NOT be eligible for participationXx_NEWLINE_xXFemale patients who are lactating must agree to stop breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding.Xx_NEWLINE_xXThe participant is pregnant or breast-feedingXx_NEWLINE_xXThe subject is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding females.Xx_NEWLINE_xXCurrent pregnancy or breast feeding; pregnant women are excluded from this study; breastfeeding should be\r\ndiscontinued in all female subjectsXx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXThe participant is pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXFemales who are pregnant or breast feeding are excluded since there are unknown teratogenic effects of these agentsXx_NEWLINE_xXParticipant is breast feeding or pregnant.Xx_NEWLINE_xXWomen who are breast feeding.Xx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking the study drugs)Xx_NEWLINE_xXFemale patients who are pregnant (per institutional practice) or breast-feeding.Xx_NEWLINE_xXA woman who is pregnant, breast-feeding, or planning to become pregnant while enrolled in this study or within 5 months after the last dose of study drugXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXNot pregnant or breast feedingXx_NEWLINE_xXNot breast feeding at any time during the study.Xx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXBreast feedingXx_NEWLINE_xXThe patient is pregnant or breast feeding.Xx_NEWLINE_xXAre pregnant or breast-feeding patients or any patient with childbearing potential not using adequate pregnancy prevention (site-specific criteria applying to Avera only)Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or nursing women are excluded from this study, breast feeding should be discontinuedXx_NEWLINE_xXSubject is pregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or are breast feeding.Xx_NEWLINE_xXSubject who is pregnant (as confirmed by pregnancy test), planning on becoming pregnant during the follow-up period, or actively breast-feeding; andXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXFemale subject is pregnant or breast-feeding; lactating females must agree not to breastfeed while taking lenalidomideXx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or active breast feedingXx_NEWLINE_xXPregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or currently breast feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemales of child-bearing potential cannot be pregnant or breast-feeding; female participants >= 10 years of age or post-menarchal must have a negative serum or urine pregnancy test within 24 hours prior to beginning treatment; female participants who are breast feeding must agree to stop breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant and breast-feeding patients are not eligible for the studyXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen may not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding females are excludedXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking lenalidomide).Xx_NEWLINE_xXPregnant or breast feeding.Xx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXPregnancy and breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXWomen who are nursing must discontinue breast-feeding prior to the enrollment in the trialXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feeding womenXx_NEWLINE_xXA female patient who is pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding at enrollmentXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXBreast feeding or pregnant.Xx_NEWLINE_xXPatients must not be women who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this study due to risks of fetal and teratogenic adverse events as seen in animal/human studies. Women of childbearing age must obtain a pregnancy test and pregnant or breast feeding females are excludedXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnancy or mothers who are breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding woman will not be entered on this studyXx_NEWLINE_xXPregnant, breast feeding, or planning to become pregnantXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXThe patient is pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feeding within 30 days prior to enrollmentXx_NEWLINE_xXPregnancy and breast feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXFemale subjects who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXSubject is pregnant, breast-feeding or lactating.Xx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding females.Xx_NEWLINE_xXPregnant or breast-feeding females.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXBreast feeding after pregnantXx_NEWLINE_xXPatient is pregnant or breast feeding.Xx_NEWLINE_xXPregnant or currently breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXBreast-feeding at screening or planning to become pregnant during the course of therapyXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXCurrently pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feeding at time of Screening and throughout the study.Xx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant within 5 months after the end of treatmentXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant and breast-feeding subjectsXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPatients must not be pregnant/breast feeding and must agree to practice adequate contraception.Xx_NEWLINE_xXFemale patients who are pregnant or breast feeding are not eligibleXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding currently or are planning to do so during or up to 3 months after the end of protocol therapy.Xx_NEWLINE_xXWomen who are breast feeding are not eligibleXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding or pregnantXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXFemales who are pregnant, test positive for pregnancy, or are breast-feeding during the Screening period, or intend to become pregnant or breast-feed during the course of the study or within 30 days after last dose of study drugXx_NEWLINE_xXPregnancy or breast feeding femaleXx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant/breastfeed while on study through 5 months after the end of treatmentXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXDONOR: Pregnant or breast-feedingXx_NEWLINE_xXWomen who are breast feedingXx_NEWLINE_xXPregnant women and women who are breast-feedingXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXNot breast feedingXx_NEWLINE_xXDONOR: Not breast feedingXx_NEWLINE_xXPregnant or breast-feeding women are excludedXx_NEWLINE_xXFemales who are pregnant, test positive for pregnancy, or are breast-feeding during the Screening period, or intend to become pregnant or breast-feed during the course of the study or within 30 days after last dose of study drugXx_NEWLINE_xXPregnant or breast-feeding women are NOT eligible; pregnancy tests must be obtained in females who are post-menarchalXx_NEWLINE_xXIf female, is pregnant or is breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXBreast feeding or pregnantXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXPregnant or breast feeding females are excludedXx_NEWLINE_xXWomen who are breast-feedingXx_NEWLINE_xXBreast-feeding at screening or planning to become pregnant during the course of therapyXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or currently breast-feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant, lactating or breast feeding womanXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXSubjects who are pregnant or breast-feedingXx_NEWLINE_xXPatient is breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXThe patient is pregnant or breast-feedingXx_NEWLINE_xXPregnant and breast-feeding femalesXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXBreast feedingXx_NEWLINE_xXBreast-feeding, pregnant, or likely to become pregnant during the studyXx_NEWLINE_xXFemale participants of child-bearing potential cannot be pregnant or breast-feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXWomen that are currently breast feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXBreast feeding womenXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast feeding women due potential damage to the fetusXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXFemale subjects who are pregnant or breast-feeding, or planning to become pregnant during study treatment and through 3 months after the last dose of study treatmentXx_NEWLINE_xXBreast feeding womenXx_NEWLINE_xXPregnant, lactating or breast feeding womenXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this studyXx_NEWLINE_xXBreast feeding and/or pregnant womenXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen of child-bearing potential who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this studyXx_NEWLINE_xXPregnant and breast feeding womenXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemale patients who are lactating must agree to stop breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXAre pregnant or breast-feeding women.Xx_NEWLINE_xXPregnant or breast-feeding females are excludedXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXTREATMENT: Pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant or are breast-feedingXx_NEWLINE_xXSubjects who are breast-feeding and plan to continue breast-feeding during therapy, or have a positive pregnancy test will be excluded from the study; should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediatelyXx_NEWLINE_xXFemale patients who are lactating must agree to stop breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnancy, breast-feeding or planning to become pregnantXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnancy or breast feeding. Due to the potential teratogenic effects of retinoids, pregnant women are NOT eligible. Breast milk feeding by study patient is NOT allowedXx_NEWLINE_xXBreast feeding femalesXx_NEWLINE_xXActive breast-feeding is also not allowed on study enrollmentXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or unwillingness to stop breast-feedingXx_NEWLINE_xXPregnant or breast-feeding patientsXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feeding females; (lactating females must agree not to breast-feed while taking lenalidomide)Xx_NEWLINE_xXWomen of childbearing potential without effective contraception as well as pregnant or breast feeding women.Xx_NEWLINE_xXThe subject is pregnant or breast-feedingXx_NEWLINE_xXRelapsed/refractory MCL: Pregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast feeding (female of child-bearing potential)Xx_NEWLINE_xXNot breast feedingXx_NEWLINE_xXDONOR: Not breast feedingXx_NEWLINE_xXDONOR: Pregnant or breast-feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXPregnant or breast-feeding females; lactating females must agree not to breast-feed while taking lenalidomideXx_NEWLINE_xXPatients who are pregnant or breast-feeding.Xx_NEWLINE_xXPatients who are pregnant or breast-feeding.Xx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXIf female, subject is pregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXBreast feeding (if lactating, must agree not to breast feed while taking pomalidomide)Xx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXWomen of child-bearing potential who are pregnant or breast feedingXx_NEWLINE_xXKnown pregnancy or breast feedingXx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXPregnant or breast-feeding patientsXx_NEWLINE_xXKnown pregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women are excludedXx_NEWLINE_xXPregnant or breast-feeding patients are excluded from this studyXx_NEWLINE_xXNot pregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding women due to the known birth defects association with the treatments used in this studyXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feeding females. (Lactating females must agree not to breast feed while taking lenalidomide).Xx_NEWLINE_xXPatient is pregnant or breast-feeding.Xx_NEWLINE_xXWomen who are breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXFemales who are pregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant, breast-feeding, or planning to become pregnantXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding;Xx_NEWLINE_xXPregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant, planning to become pregnant, or breast feeding.Xx_NEWLINE_xXBreast feeding women.Xx_NEWLINE_xXFemale patients who are breast-feeding.Xx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemale patients should not be pregnant or breast?feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXFemale patients must not be pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXBe female and pregnant or breast feeding.Xx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant within 5 months after the end of treatmentXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXIndividuals who are pregnant or breast feeding or who become pregnant while enrolled on this trial will be excluded from participationXx_NEWLINE_xXPregnant or breast feeding females.Xx_NEWLINE_xXPregnant or breast feeding women are excluded from this studyXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are actively breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are nursing must discontinue breast-feeding prior to the enrollment in the trialXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXWomen who are breast feedingXx_NEWLINE_xXParticipants cannot be breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXBreast feeding women are not eligibleXx_NEWLINE_xXFor women of childbearing potential, no pregnancy or breast-feedingXx_NEWLINE_xX-  Pregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding patientsXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXFemale who is pregnant or breast feeding and HCV treatment requires use of ribavirinXx_NEWLINE_xXPregnant or breast-feeding women, due to the unknown effects of GI-6207 on the fetus or infantXx_NEWLINE_xXBreast feeding womenXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPatients known or found to be pregnant or who is unwilling to stop breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast-feeding (lactating) women or women who plan to become pregnant or breast-feed during the studyXx_NEWLINE_xXCurrently breast feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding female patientXx_NEWLINE_xXThey are pregnant or breast feeding.Xx_NEWLINE_xXPatients that are pregnant, breast feeding, or unwilling to use effective contraception during the studyXx_NEWLINE_xXFemale participant who is pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast feedingXx_NEWLINE_xXIs pregnant or breast-feedingXx_NEWLINE_xXSubject is pregnant or breast-feeding. Women must not breast-feed until at 5 months after completion of study participation..Xx_NEWLINE_xXCurrently pregnant or breast-feedingXx_NEWLINE_xXThe patient is pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXFemale participants who are lactating, breast feeding, or pregnant.Xx_NEWLINE_xXFemale subject who is pregnant or breast-feeding, or any subject expecting to conceive or father a child during this study;Xx_NEWLINE_xXNon pregnant, non-breast feeding females under active contraceptionXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPatients who are breast-feedingXx_NEWLINE_xXPregnancy or breast feeding motherXx_NEWLINE_xXPregnant or breast-feeding females or females who intend to become pregnant during study participation.Xx_NEWLINE_xXFemale patients who are pregnant or breast feeding are not eligibleXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXSubject is pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemale subjects who are pregnant or breast feedingXx_NEWLINE_xXWomen who are either breast feeding or pregnant.Xx_NEWLINE_xXCurrently pregnant or breast-feeding, or planning to become pregnant during study treatment and through 3 months after the last dose of study treatmentXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXSubject is pregnant or breast feedingXx_NEWLINE_xXBreast-feeding womenXx_NEWLINE_xXPatients who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXWomen who are pregnant or breast feeding are not to be included.Xx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast feeding patientsXx_NEWLINE_xXFemales must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or lactating/breast-feeding women.Xx_NEWLINE_xXWomen of child-bearing potential who are pregnant or breast feedingXx_NEWLINE_xXSubjects are pregnant or breast-feeding at entry.Xx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnancy and breast feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feeding, or intends to become pregnant during the studyXx_NEWLINE_xXFemales who are pregnant or breast feeding are not eligible for this studyXx_NEWLINE_xXThe patient is pregnant or breast feeding.Xx_NEWLINE_xXFemales who are breast-feeding or pregnantXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXNot pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this study; women of child-bearing age must obtain a pregnancy test, and pregnant or breast feeding females are excludedXx_NEWLINE_xXSubject is pregnant, planning on becoming pregnant during the follow-up period, or actively breast-feeding;Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXIs pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding at time of consentXx_NEWLINE_xXPatient is pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXParticipant is pregnant or breast feeding.Xx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXFemale subject is pregnant or breast-feedingXx_NEWLINE_xXA female patient who is pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast-feeding females; patients who become pregnant during active therapy will be immediately removed from the studyXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXFemale participants pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding patientsXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXFemale subject is pregnant or breast-feeding, or planning to become pregnant during study treatment and through 3 months after the last dose of talimogene laherparepvecXx_NEWLINE_xXThe subject is pregnant or breast-feedingXx_NEWLINE_xXIf female, patient is pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feeding female patients;Xx_NEWLINE_xXPatients who are pregnant or breast-feeding are not eligible for this study; negative pregnancy tests must be obtained in female patients who are postmenarchalXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXWomen who are breast feedingXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding or pregnantXx_NEWLINE_xXPregnant or breast-feeding female patientsXx_NEWLINE_xXFemale patients who are lactating must agree to stop breast-feedingXx_NEWLINE_xXBreast feeding or pregnant.Xx_NEWLINE_xXPregnant, lactating, or breast feeding womenXx_NEWLINE_xXPregnancy or breast-feeding womenXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding or pregnantXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXSubjects who are pregnant or breast feeding.Xx_NEWLINE_xXPatients who are currently pregnant, planning to become pregnant, or breast-feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXLactating women who are breast-feedingXx_NEWLINE_xXFemale participants pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXBreast feeding women.Xx_NEWLINE_xXPregnant patients or currently breast-feedingXx_NEWLINE_xXPatient is pregnant or breast feeding, or planning to become pregnant within 5 months after the end of treatmentXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXWomen who are pregnant or breast-feeding and women or men not practicing effective birth controlXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding patientsXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant patients or women who are breast-feeding (patients must be postmenopausal)Xx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant or breast feeding are NOT eligible for participationXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXWomen of child-bearing potential who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking pomalidomide)Xx_NEWLINE_xXBreast feeding femalesXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXFemales who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding; pregnancy testing will be performed on all menstruating females within 14 days prior to study enrollmentXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXFemale patient pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXBreast feeding (Female only)Xx_NEWLINE_xXDONOR: Breast feeding (Female only)Xx_NEWLINE_xXWomen of childbearing potential who are pregnant or breast feeding.Xx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXFemale participants who were breast feeding or pregnant.Xx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXFor women only - currently pregnant or breast feeding.Xx_NEWLINE_xXPatients who are breast-feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPatients who are pregnant or breast-feeding will NOT be eligible for participationXx_NEWLINE_xXPregnancy or breast-feeding womenXx_NEWLINE_xXPregnant or breast feeding females.Xx_NEWLINE_xXPregnant (positive serum pregnancy test) or breast feedingXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXFemale subject is pregnant or breast-feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXPregnant or breast-feeding; pregnancy testing will be performed on all menstruating females within 14 days prior to study enrollmentXx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXPregnant or breast feeding females.(Lactating females must agree not to breast feed while taking lenalidomide).Xx_NEWLINE_xXPregnant, inadequate contraception, breast feedingXx_NEWLINE_xXLactating or breast feeding femalesXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast feeding females are not eligibleXx_NEWLINE_xXFemales who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding must be discontinuedXx_NEWLINE_xXPregnant or breast-feeding females; (lactating females must agree not to breast feed while taking Revlimid)Xx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide or azacitidine)Xx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXA woman who is pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXFemales who are pregnant or are breast-feeding.Xx_NEWLINE_xXBreast feeding women;Xx_NEWLINE_xXPregnant women; breast feeding should be discontinued during treatmentXx_NEWLINE_xXWomen who are pregnant or breast-feeding and women or men not practicing effective birth controlXx_NEWLINE_xXPatient is pregnant or breast feeding or expecting to conceive or father children within the projected duration of the study, because of the potential for serious adverse reactions in nursing infants from vorinostat, breast feeding must be discontinued for the duration of therapy with vorinostatXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXFor females, if they are pregnant or breast-feedingXx_NEWLINE_xXPregnant or intending to become pregnant or breast-feeding patentsXx_NEWLINE_xXBreast feedingXx_NEWLINE_xXPregnant or breast-feeding women are excludedXx_NEWLINE_xXFertile females who are unwilling to use contraceptive techniques during and for the twelve months following treatment, as well as females who are pregnant or actively breast feedingXx_NEWLINE_xXPregnant (positive pregnancy test) or breast feedingXx_NEWLINE_xXPregnant or breast-feeding women are ineligibleXx_NEWLINE_xXFemale subject is pregnant or breast-feeding.Xx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding femaleXx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXSubject who is pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking ibrutinib or idelalisib)Xx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feeding patients.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant within 7 months after the end of treatment.Xx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXIs pregnant or breast-feedingXx_NEWLINE_xXWomen who are breast-feeding or pregnant.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant, lactating or breast feeding womenXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXSubjects who are pregnant or are breast-feedingXx_NEWLINE_xXWomen currently pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding women are excluded.Xx_NEWLINE_xXFemales who are breast-feeding or pregnantXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXFemale participants who are breast-feedingXx_NEWLINE_xXPregnant (positive serum pregnancy test) or breast feedingXx_NEWLINE_xXPatients may not be pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXare pregnant or breast-feeding.Xx_NEWLINE_xXAre pregnant and or breast feeding.Xx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXBreast feeding or pregnant femalesXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen who are breast feeding or pregnant as evidenced by pregnancy test.Xx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXIf female, is pregnant or breast-feeding;Xx_NEWLINE_xXFemale participants who are pregnant, lactating, or breast-feedingXx_NEWLINE_xXPregnant women and women who are breast-feedingXx_NEWLINE_xXBreast-feeding womenXx_NEWLINE_xXBreast feeding or pregnant femalesXx_NEWLINE_xXPatients who are pregnant or breast-feeding.Xx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXIf female, is lactating or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXSubjects who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feeding within the projected duration of trial participation through 4 months after the last dose of study treatment.Xx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXIs pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXBreast feeding femalesXx_NEWLINE_xXCurrently pregnant or breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feeding are not to be included.Xx_NEWLINE_xXPregnant women or women presently breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding females.Xx_NEWLINE_xXBreast feedingXx_NEWLINE_xXPregnancy/Breast feedingXx_NEWLINE_xXNot breast feedingXx_NEWLINE_xXDONOR: Not breast feedingXx_NEWLINE_xXPatient is breast feedingXx_NEWLINE_xXNot breast feedingXx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this studyXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feeding.Xx_NEWLINE_xXIs pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXWomen of childbearing potential who are pregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXPregnant, lactating or actively breast feeding females.Xx_NEWLINE_xXPregnant or breast-feeding women and women of childbearing age who are unwilling to use adequate contraceptionXx_NEWLINE_xXBreast feeding womenXx_NEWLINE_xXPregnant or breast feeding females (lactating females must agree not to breast feed while taking ipilimumab)Xx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast feeding females; lactating females must agree not to breast feed while taking lenalidomideXx_NEWLINE_xXPregnant or breast feeding women and males who do not agree to use condom during the sexual contact with females of childbearing potential.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant and/or breast-feeding women.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXFemales in the study must not be pregnant or breast feeding and not planning to become pregnant or breast feed for the duration of the study, and for at least three months after study completionXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this study due to risks of fetal and teratogenic adverse events.Xx_NEWLINE_xXThe patient is pregnant or breast feeding.Xx_NEWLINE_xXBreast feeding femalesXx_NEWLINE_xXSubjects who are pregnant or are breast-feeding.Xx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXLactating females who are actively breast feeding.Xx_NEWLINE_xXNot breast feedingXx_NEWLINE_xXDONOR: Not breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPatients who are pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast-feeding women.Xx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXWomen of child-bearing potential who are pregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXNot pregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feeding.Xx_NEWLINE_xXWomen who are currently pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding females; (lactating females must agree not to breast feed while taking lenalidomide)Xx_NEWLINE_xXFemale patients who are lactating must agree to stop breast-feedingXx_NEWLINE_xXpregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPatients must not be pregnant or breast feeding and must practice adequate contraceptionXx_NEWLINE_xXPatient is pregnant or nursing/breast-feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding.Xx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant within 5 months after the end of treatmentXx_NEWLINE_xXPregnant or breast-feeding, or planning to become pregnant during study treatment and within 2 months after the last administration of investigational product.Xx_NEWLINE_xXWomen who are pregnant or breast feeding.Xx_NEWLINE_xXIf you are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXPregnant or breast-feeding (lactating) women or women who plan to become pregnant or breast-feed during the studyXx_NEWLINE_xXPregnancy or breast-feeding:\r\n* Pregnant or breast-feeding women may not be entered on this study; pregnancy tests must be obtained in girls who are post-menarchal\r\n* Males or females of reproductive potential may not participate unless they have agreed to use an effective double barrier contraceptive method for the entire duration of protocol therapyXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant, become pregnant, or are breast-feedingXx_NEWLINE_xXWomen who are currently breast-feeding are not eligible for this studyXx_NEWLINE_xXCurrently pregnant or breast-feedingXx_NEWLINE_xXFemale patients who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding women.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXMust not be pregnant or breast feedingXx_NEWLINE_xXFemales who are pregnant or might be pregnant or are breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feeding will not be included in the studyXx_NEWLINE_xXMay not be pregnant, lactating or breast feedingXx_NEWLINE_xXCurrent pregnancy and breast feedingXx_NEWLINE_xXNot pregnant or breast?feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnant and/or breast feeding if a female recipientXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPatients who are pregnant or breast feedingXx_NEWLINE_xXFemales who are pregnant or breast feedingXx_NEWLINE_xXPregnant and breast-feeding women are ineligibleXx_NEWLINE_xXFemales who are pregnant, breast-feeding or intending to become pregnant; this exclusion criterion will be assessed by questioning the patient about the pregnancy status, breast-feeding status, the intent to become pregnant, the menopausal status, and the date of the last menstrual periodXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXLactation or breast feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant women or women who are breast feeding are not eligible for the studyXx_NEWLINE_xXPregnant or breast-feeding.Xx_NEWLINE_xXFemales who are pregnant or breast feeding at the time of screening will not be eligible for this studyXx_NEWLINE_xXSubject is not pregnant or breast feeding, and cannot become pregnant within 30 days after the end of treatmentXx_NEWLINE_xXSubject is pregnant or breast feeding, or planning to become pregnant within 5 months after end of treatmentXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant or breast feeding femalesXx_NEWLINE_xXPregnant patients or actively breast-feedingXx_NEWLINE_xXWomen who are currently pregnant or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xX(Female only) Breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXAt the beginning of the study, pregnant women and women who are breast-feeding will not be enrolledXx_NEWLINE_xXCONTROL (HEALTHY) GROUP: At the beginning of the study, pregnant women and women who are breast-feeding will not be enrolledXx_NEWLINE_xXBreast feedingXx_NEWLINE_xXWomen must be one year from pregnancy and breast-feedingXx_NEWLINE_xXWomen currently pregnant or breast-feeding at time of study consentXx_NEWLINE_xXParticipants who have a positive pregnancy test, are pregnant, or breast feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXPregnant and/or breast-feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXPatient is pregnant or breast-feedingXx_NEWLINE_xXPregnancy/breast feeding: females who are pregnant or breast feeding at the time of study entry are not eligibleXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPatients who are pregnant, planning pregnancy, or breast feedingXx_NEWLINE_xXNot be currently pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding womenXx_NEWLINE_xXPregnancy or breast-feeding.Xx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXWomen who are currently pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXBreast feedingXx_NEWLINE_xXIs pregnant or breast feedingXx_NEWLINE_xXFemale patients who are pregnant or breast feedingXx_NEWLINE_xXFemale subjects must not be pregnant or breast feeding within 6 months prior to and during course of studyXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant women or those who are breast feedingXx_NEWLINE_xXChildren, minors, pregnant women, women who are breast feeding, institutionalized patientsXx_NEWLINE_xXKnown pregnancy or breast-feedingXx_NEWLINE_xXPatient must NOT be pregnant or breast-feedingXx_NEWLINE_xXWomen that are pregnant or breast-feedingXx_NEWLINE_xXNot pregnant or breast feedingXx_NEWLINE_xXPregnant, lactating, or breast feeding womenXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXPatients who are currently pregnant or breast feeding; a pregnancy test within 72 hours of the first PET/MRI will be performedXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXBreast feeding / pregnancyXx_NEWLINE_xXPregnant or currently breast-feedingXx_NEWLINE_xXBreast-feedingXx_NEWLINE_xXPregnant women or women who are breast-feedingXx_NEWLINE_xXPregnant women or women who are breast feedingXx_NEWLINE_xXKnown pregnancy or breast-feedingXx_NEWLINE_xXWomen who are pregnant of breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXBreast feeding/pregnancyXx_NEWLINE_xXBreast-feedingXx_NEWLINE_xXPregnancy or lactating with the intent of breast feedingXx_NEWLINE_xXSubjects who are pregnant or breast feedingXx_NEWLINE_xXNo breast-feedingXx_NEWLINE_xXKnown pregnancy or breast-feedingXx_NEWLINE_xXNot pregnant or breast-feedingXx_NEWLINE_xXNot pregnant or breast feedingXx_NEWLINE_xXPatient Volunteers/Contrast Enhancement Sub-group: Not pregnant or breast-feedingXx_NEWLINE_xXBreast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnancy or breast feedingXx_NEWLINE_xXFemale patients cannot be pregnant or breast feedingXx_NEWLINE_xXOVARIAN CANCER PARTICIPANTS: Patient is pregnant or breast-feedingXx_NEWLINE_xXBREAST CANCER PARTICIPANTS: Patient is pregnant or breast-feedingXx_NEWLINE_xXWomen who are pregnant or breast-feedingXx_NEWLINE_xXNot breast-feeding, if applicableXx_NEWLINE_xXWomen who are either pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feeding womenXx_NEWLINE_xXPregnancy or breast-feedingXx_NEWLINE_xXPregnant or breast feeding.Xx_NEWLINE_xXPregnant or breast-feeding femalesXx_NEWLINE_xXFemale pregnant or breast feedingXx_NEWLINE_xXPatients who are pregnant or are breast feedingXx_NEWLINE_xXPatients who are pregnant, breast-feeding or are planning to become pregnant during the study durationXx_NEWLINE_xXIs breast-feeding or pregnantXx_NEWLINE_xXpregnancy or breast-feedingXx_NEWLINE_xXSubjects who are pregnant or breast feedingXx_NEWLINE_xXWomen must not be pregnant or breast-feedingXx_NEWLINE_xXPregnant or breast feeding female patientXx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXThe patient is pregnant or breast feedingXx_NEWLINE_xXWomen who are pregnant or breast feedingXx_NEWLINE_xXPregnant or breast-feedingXx_NEWLINE_xXPregnant women or women who are breast feedingXx_NEWLINE_xXParticipant is pregnant or breast-feedingXx_NEWLINE_xXPatients who are breast feedingXx_NEWLINE_xXthe safety or well-being of the participant's offspring (such as through pregnancy or breast-feeding)Xx_NEWLINE_xXPregnancy and contraception: Subjects who are pregnant, breast-feeding or planning to conceive within 30 days are not eligibleXx_NEWLINE_xXPregnant or breast feeding womenXx_NEWLINE_xXPatient is pregnant or breast feeding, or planning to become pregnant while enrolled in the study, up to the End of Study visitXx_NEWLINE_xXPregnant or breast feedingXx_NEWLINE_xXFemale subject is pregnant or breast-feeding, or planning to become pregnant during study treatment and through 3 months after the last dose of talimogene laherparepvec.Xx_NEWLINE_xXPatient is pregnant or breast feeding, or planning to become pregnant while enrolled in the study, up to the End of Study visitXx_NEWLINE_xXPatient is pregnant or breast-feeding.Xx_NEWLINE_xXPregnant or breast-feeding women will not be entered on this study; women of child-bearing age must obtain a pregnancy test and pregnant or breast feeding females are excludedXx_NEWLINE_xX